Clinical and Laboratory Factors for the Progression of Severe Dengue Among Hospitalized Patients During an Upsurge
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 324
- 试验地点
- 1
- 主要终点
- Laboratory infection markers and immune parameters
研究概览
简要总结
Hypothesis (if any): Not applicable Objectives: To identify factors for progression to severe Dengue in hospitalized patients.
Methods: Prospective Observational study
详细描述
Global perspective:
Mosquito-borne dengue is a global public health issue in the tropics and subtropics. Dengue is endemic in over 100 countries, according to WHO. Around 40% of the world's population-3.6 billion-lives in dengue-endemic areas. Dengue infects 400 million people, sickens 100 million, and kills 21,000 each year. In studies of acute febrile illness in US visitors returning from South-central and Southeast Asia, South America, Mexico, and the Caribbean, dengue is the main cause due to increased international travel and the popularity of dengue-endemic destinations. Thus, dengue-related US hospitalizations are rising. Prevention methods, such as early detection and prompt clinical therapy, can lower case fatality rates from 10% to <1%.
National perspective:
Dengue has been hyperendemic in Bangladesh since 2000. The current dengue spike is exceptional in its seasonality and an early fast increase compared to past years, which began in late June. According to WHO, this year's case fatality rate is 0.47%, higher than usual. However, Bangladeshi clinical spectrum, serotype predominance, novel and modified serotypes (DEVN-5), and immunological responses need more research. However, future dengue prevention and treatment techniques require serotype-specific clinical and laboratory indicators and immune reactivity in distinct spectrums.
This research is conducted in hospitals to identify the burden of severe dengue and its link to dengue fever in our country. Dengue fever is now managed supportively without antiviral medication. The cause of severe and potentially deadly dengue is unknown. Prior DENV exposure, co-morbidity, and genetic predisposition may increase the risk of severe dengue sickness. The study results will help us understand and solve the problem. The aim is to assess the clinical and laboratory parameters related to severe Dengue and the transition from non-severe to severe Dengue in hospitalized Bangladeshis.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 1 Year 至 70 Years(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Dengue fever with warning signs with Ns1 positive and or IgM positive
- •Informed written consent or assent.
排除标准
- •Severe dengue during screening or denied consenting
结局指标
主要结局
Laboratory infection markers and immune parameters
时间窗: 01/01/2024 to 30/06/2025
Laboratory biomarkers, immune factor, serotyping
Host factors & comorbidities
时间窗: January 01- June 30; 2025
Association with age, sex, co-morbid condition, care seeking behaviours
Sociodemographic factors
时间窗: On admission
Resident, occupation, monthly income, living condition, health-seeking behaviors
Clinical progression parameters during hospitalization
时间窗: January 01, 2024 to December 31, 2024
Clinical sign symptoms during admission and then differences at final outcome, such as on discharge or in death.
次要结局
未报告次要终点
